Literature DB >> 20203061

Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease.

Zhigang Wang1, Tong Yao, Maria Pini, Zhanxiang Zhou, Giamila Fantuzzi, Zhenyuan Song.   

Abstract

Adipose tissue dysfunction, featured by insulin resistance and/or dysregulated adipokine production, plays a central role not only in disease initiation but also in the progression to nonalcoholic steatohepatitis and cirrhosis. Promising beneficial effects of betaine supplementation on nonalcoholic fatty liver disease (NAFLD) have been reported in both clinical investigations and experimental studies; however, data related to betaine therapy in NAFLD are still limited. In this study, we examined the effects of betaine supplementation on hepatic fat accumulation and injury in mice fed a high-fat diet and evaluated mechanisms underlying its hepatoprotective effects. Male C57BL/6 mice weighing 25 +/- 0.5 (SE) g were divided into four groups (8 mice/group) and started on one of four treatments: control diet, control diet supplemented with betaine, high-fat diet, and high-fat diet supplemented with betaine. Betaine was supplemented in the drinking water at a concentration of 1% (wt/vol) (anhydrous). Our results showed that long-term high-fat feeding caused NAFLD in mice, which was manifested by excessive neutral fat accumulation in the liver and elevated plasma alanine aminotransferase levels. Betaine supplementation alleviated hepatic pathological changes, which were concomitant with attenuated insulin resistance as shown by improved homeostasis model assessment of basal insulin resistance values and glucose tolerance test, and corrected abnormal adipokine (adiponectin, resistin, and leptin) productions. Specifically, betaine supplementation enhanced insulin sensitivity in adipose tissue as shown by improved extracellular signal-regulated kinases 1/2 and protein kinase B activations. In adipocytes freshly isolated from mice fed a high-fat diet, pretreatment of betaine enhanced the insulin signaling pathway and improved adipokine productions. Further investigation using whole liver tissues revealed that betaine supplementation alleviated the high-fat diet-induced endoplasmic reticulum stress response in adipose tissue as shown by attenuated glucose-regulated protein 78/C/EBP homologous protein (CHOP) protein abundance and c-Jun NH(2)-terminal kinase activation. Our findings suggest that betaine might serve as a safe and efficacious therapeutic tool for NAFLD by improving adipose tissue function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203061      PMCID: PMC2867421          DOI: 10.1152/ajpgi.00249.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  40 in total

Review 1.  Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance.

Authors:  Herbert Tilg; Gökhan S Hotamisligil
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

2.  Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.

Authors:  Gürol Tuncman; Jiro Hirosumi; Giovanni Solinas; Lufen Chang; Michael Karin; Gökhan S Hotamisligil
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

3.  Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.

Authors:  Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

4.  The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307).

Authors:  V Aguirre; T Uchida; L Yenush; R Davis; M F White
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 5.  Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Authors:  Geoffrey C Farrell; Claire Z Larter
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

6.  The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance.

Authors:  Cullen M Taniguchi; José O Aleman; Kohjiro Ueki; Ji Luo; Tomoichiro Asano; Hideaki Kaneto; Gregory Stephanopoulos; Lewis C Cantley; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

7.  HGF ameliorates a high-fat diet-induced fatty liver.

Authors:  Takashi Kosone; Hitoshi Takagi; Norio Horiguchi; Yasuyo Ariyama; Toshiyuki Otsuka; Naondo Sohara; Satoru Kakizaki; Ken Sato; Masatomo Mori
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-03-29       Impact factor: 4.052

8.  Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?

Authors:  Roberto Gambino; Maurizio Cassader; Gianfranco Pagano; Marilena Durazzo; Giovanni Musso
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

9.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

Review 10.  Pioglitazone for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C Clar; S H Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18
View more
  47 in total

1.  Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine.

Authors:  Elango Kathirvel; Kengathevy Morgan; Ganesh Nandgiri; Brian C Sandoval; Marie A Caudill; Teodoro Bottiglieri; Samuel W French; Timothy R Morgan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

2.  Homocysteine suppresses lipolysis in adipocytes by activating the AMPK pathway.

Authors:  Zhigang Wang; Maria Pini; Tong Yao; Zhanxiang Zhou; Changhao Sun; Giamila Fantuzzi; Zhenyuan Song
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-12       Impact factor: 4.310

3.  25th European Congress on Obesity, Vienna, Austria, May 23-26, 2018: Abstracts.

Authors: 
Journal:  Obes Facts       Date:  2018-05-26       Impact factor: 3.942

4.  Effects of post-weaning diet on metabolic parameters and DNA methylation status of the cryptic promoter in the A(vy) allele of viable yellow mice.

Authors:  Denise A Warzak; Sarah A Johnson; Mark R Ellersieck; R Michael Roberts; Xiang Zhang; Shuk-Mei Ho; Cheryl S Rosenfeld
Journal:  J Nutr Biochem       Date:  2015-02-26       Impact factor: 6.048

5.  Metabolite and gene expression profiles suggest a putative mechanism through which high dietary carbohydrates reduce the content of hepatic betaine in Megalobrama amblycephala.

Authors:  Jia Xu; Fan Wang; Ivan Jakovlić; Wassana Prisingkorn; Jun-Tao Li; Wei-Min Wang; Yu-Hua Zhao
Journal:  Metabolomics       Date:  2018-07-04       Impact factor: 4.290

6.  Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue.

Authors:  Ya-Wen Teng; Jessica M Ellis; Rosalind A Coleman; Steven H Zeisel
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

7.  Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.

Authors:  Xiaobing Dou; Yongliang Xia; Jing Chen; Ying Qian; Songtao Li; Ximei Zhang; Zhenyuan Song
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 8.  Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.

Authors:  Alessandro Federico; Claudio Zulli; Ilario de Sio; Anna Del Prete; Marcello Dallio; Mario Masarone; Carmela Loguercio
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 9.  Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.

Authors:  Steven H Zeisel
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

Review 10.  Epigenetics in adipose tissue, obesity, weight loss, and diabetes.

Authors:  J Alfredo Martínez; Fermín I Milagro; Kate J Claycombe; Kevin L Schalinske
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.